|
1
|
A multidimensional conceptual framework for analysing public involvement in health services research.
|
Health Expect
|
2008
|
2.93
|
|
2
|
Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.
|
BMJ
|
2005
|
2.59
|
|
3
|
Hyperacute stroke care and NHS England's business plan.
|
BMJ
|
2014
|
1.57
|
|
4
|
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer.
|
BJU Int
|
2011
|
1.51
|
|
5
|
Cost-effectiveness of dasatinib and nilotinib for imatinib-resistant or -intolerant chronic phase chronic myeloid leukemia.
|
Value Health
|
2011
|
1.48
|
|
6
|
The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective.
|
Nephrol Dial Transplant
|
2007
|
1.47
|
|
7
|
Public health implications of establishing a national programme to screen young athletes in the UK.
|
Br J Sports Med
|
2009
|
1.38
|
|
8
|
Comparison of treatment effect sizes associated with surrogate and final patient relevant outcomes in randomised controlled trials: meta-epidemiological study.
|
BMJ
|
2013
|
1.22
|
|
9
|
The experience of heavy menstrual bleeding: a systematic review and meta-ethnography of qualitative studies.
|
J Adv Nurs
|
2008
|
1.21
|
|
10
|
Temozolomide for high grade glioma.
|
Cochrane Database Syst Rev
|
2013
|
1.15
|
|
11
|
Temozolomide for high grade glioma.
|
Cochrane Database Syst Rev
|
2008
|
1.11
|
|
12
|
Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness.
|
Am J Rhinol
|
2006
|
1.11
|
|
13
|
Factors influencing the implementation of fall-prevention programmes: a systematic review and synthesis of qualitative studies.
|
Implement Sci
|
2012
|
1.06
|
|
14
|
Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review.
|
BMC Fam Pract
|
2006
|
1.05
|
|
15
|
Can the retinal screening interval be safely increased to 2 years for type 2 diabetic patients without retinopathy?
|
Diabetes Care
|
2012
|
1.03
|
|
16
|
Chemotherapy wafers for high grade glioma.
|
Cochrane Database Syst Rev
|
2011
|
1.02
|
|
17
|
Maximizing the population benefit from thrombolysis in acute ischemic stroke: a modeling study of in-hospital delays.
|
Stroke
|
2012
|
1.01
|
|
18
|
Cost-effectiveness of temsirolimus for first line treatment of advanced renal cell carcinoma.
|
Value Health
|
2009
|
0.92
|
|
19
|
Telephone consultations in place of face to face out-patient consultations for patients discharged from hospital following surgery: a systematic review.
|
BMC Health Serv Res
|
2013
|
0.92
|
|
20
|
Patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review of patient reported outcomes and patient and clinician satisfaction.
|
BMC Health Serv Res
|
2013
|
0.92
|
|
21
|
The clinical effectiveness of patient initiated clinics for patients with chronic or recurrent conditions managed in secondary care: a systematic review.
|
PLoS One
|
2013
|
0.90
|
|
22
|
Carmustine implants for the treatment of newly diagnosed high-grade gliomas: a cost-utility analysis.
|
Pharmacoeconomics
|
2008
|
0.90
|
|
23
|
Effectiveness of mealtime interventions on nutritional outcomes for the elderly living in residential care: a systematic review and meta-analysis.
|
Ageing Res Rev
|
2013
|
0.89
|
|
24
|
Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia.
|
Pharmacoeconomics
|
2005
|
0.89
|
|
25
|
Will delays in treatment jeopardize the population benefit from extending the time window for stroke thrombolysis?
|
Stroke
|
2012
|
0.89
|
|
26
|
Methods to elicit probability distributions from experts: a systematic review of reported practice in health technology assessment.
|
Pharmacoeconomics
|
2013
|
0.88
|
|
27
|
Chemotherapeutic wafers for High Grade Glioma.
|
Cochrane Database Syst Rev
|
2008
|
0.88
|
|
28
|
Implementing the evidence for preventing falls among community-dwelling older people: a systematic review.
|
J Safety Res
|
2011
|
0.87
|
|
29
|
A cost-utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding.
|
BJOG
|
2004
|
0.87
|
|
30
|
Multiple component interventions for preventing falls and fall-related injuries among older people: systematic review and meta-analysis.
|
BMC Geriatr
|
2014
|
0.87
|
|
31
|
Establishing local priorities for a health research agenda.
|
Health Expect
|
2012
|
0.85
|
|
32
|
Interventions to reduce acute paediatric hospital admissions: a systematic review.
|
Arch Dis Child
|
2012
|
0.84
|
|
33
|
Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma.
|
Value Health
|
2009
|
0.84
|
|
34
|
Is combined resynchronisation and implantable defibrillator therapy a cost-effective option for left ventricular dysfunction?
|
Int J Cardiol
|
2008
|
0.83
|
|
35
|
Case finding for hepatitis C in primary care: a cost utility analysis.
|
Fam Pract
|
2006
|
0.83
|
|
36
|
Cost-effectiveness of alemtuzumab for T-cell prolymphocytic leukemia.
|
Int J Technol Assess Health Care
|
2012
|
0.79
|
|
37
|
Do metronomes improve the quality of life in people with Parkinson's disease? A pragmatic, single-blind, randomized cross-over trial.
|
Clin Rehabil
|
2010
|
0.78
|
|
38
|
Involving patients in drug licensing decisions.
|
BMJ
|
2013
|
0.77
|
|
39
|
Predictive value of asthma medication to identify asthma sufferers.
|
Br J Gen Pract
|
2002
|
0.75
|
|
40
|
Mind sharpeners for scientists: the EQUATOR Network.
|
Int J Technol Assess Health Care
|
2011
|
0.75
|
|
41
|
A rapid needs assessment of the provision of Health Technology Assessment in the south-west peninsula.
|
J Public Health (Oxf)
|
2007
|
0.75
|
|
42
|
NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia.
|
Lancet Oncol
|
2011
|
0.75
|
|
43
|
Using information graphics in health technology assessment: toward a structured approach.
|
Int J Technol Assess Health Care
|
2009
|
0.75
|
|
44
|
Adult attention deficit hyperactivity disorder (ADHD): public health implications.
|
Perspect Public Health
|
2012
|
0.75
|
|
45
|
Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis.
|
Pharmacoeconomics
|
2012
|
0.75
|
|
46
|
Microwave and thermal balloon ablation for heavy menstrual bleeding: a systematic review.
|
BJOG
|
2005
|
0.75
|
|
47
|
Erratum to: cost effectiveness of Oromucosal cannabis-based medicine (Sativex(®)) for spasticity in multiple sclerosis.
|
Pharmacoeconomics
|
2015
|
0.75
|